10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
46.27
-1.79 (-3.72%)
At close: Jul 24, 2026, 4:00 PM EDT
46.01
-0.26 (-0.56%)
After-hours: Jul 24, 2026, 7:57 PM EDT
10x Genomics Revenue
10x Genomics had revenue of $150.84M in the quarter ending March 31, 2026, a decrease of -2.61%. This brings the company's revenue in the last twelve months to $638.78M, up 2.26% year-over-year. In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth.
Revenue (ttm)
$638.78M
Revenue Growth
+2.26%
P/S Ratio
9.20
Revenue / Employee
$542,261
Employees
1,178
Market Cap
5.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 642.82M | 32.04M | 5.25% |
| Dec 31, 2024 | 610.79M | -7.94M | -1.28% |
| Dec 31, 2023 | 618.73M | 102.32M | 19.81% |
| Dec 31, 2022 | 516.41M | 25.92M | 5.28% |
| Dec 31, 2021 | 490.49M | 191.65M | 64.13% |
| Dec 31, 2020 | 298.85M | 52.95M | 21.53% |
| Dec 31, 2019 | 245.89M | 99.58M | 68.06% |
| Dec 31, 2018 | 146.31M | 75.23M | 105.83% |
| Dec 31, 2017 | 71.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 13.65B |
| Veeva Systems | 3.32B |
| Teladoc Health | 2.51B |
| Privia Health Group | 2.25B |
| Tempus AI | 1.36B |
| HealthEquity | 1.34B |
| Omnicell | 1.23B |
| Waystar Holding | 1.16B |
TXG News
- 9 days ago - 10x Genomics price target raised to $40 from $23 at Leerink - TheFly
- 10 days ago - 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 - PRNewsWire
- 11 days ago - 10x Genomics price target raised to $47 from $25 at TD Cowen - TheFly
- 12 days ago - 10x Genomics price target raised to $50 from $32 at Canaccord - TheFly
- 17 days ago - 10x Genomics price target raised to $37 from $22 at Morgan Stanley - TheFly
- 17 days ago - 10x Genomics Transcript: Transcript - Transcripts
- 18 days ago - 10x Genomics price target raised to $45 from $24 at Citi - TheFly
- 4 weeks ago - 10x Genomics price target raised to $40 from $30 at Barclays - TheFly